Global Gene Editing Technology

Gene Editing Technology Comprehensive Study by Application (Agriculture, Medical, Other), Technology (CRISPR, TALEN, ZFN, Antisense, Other), product & service (Reagents & Consumables, Software & Systems, Services), End User (Pharmaceutical Companies, Biotechnology Companies, Academic & Government Research Institutes) Players and Region - Global Market Outlook to 2030

Gene Editing Technology Market by XX Submarkets | Forecast Years 2024-2030  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
About Gene Editing Technology
Gene editing (Genome editing ) is a group of innovations that enable researchers to change a living being's DNA. These advancements in technologies permit genetic material to be added, dispensed with, or modified at specific zones in the genome. A couple of approaches to manage genome modifying have been made. An advancing one is known as CRISPR-Cas9, which is short for assembled dependably interspaced short palindromic repeats and CRISPR-related protein 9. The CRISPR-Cas9 framework has made a huge load of energy in standard researchers since it is speedier, more affordable, more exact, and more capable than other existing genome altering methods. The rise in the research and development activities and government initiatives is booming the market of Gene Editing Technology.

AttributesDetails
Study Period2018-2030
Base Year2023
UnitValue (USD Million)


The companies are exploring the market by adopting expansions, investments, new service launches, and collaborations as their preferred strategies. The players are exploring new geographies through expansions and acquisitions across the globe to gain a competitive advantage through combined collaborations. Analyst at AMA Research estimates that United States Players will contribute the maximum growth to Global Gene Editing Technology market throughout the forecasted period. Established and emerging Players should take a closer view at their existing organizations and reinvent traditional business and operating models to adapt to the future.

Thermo Fisher Scientific(United States), SIGMA ALDRICH(United States), Cellectics(France), CRISPR Therapeutics (Switzerland), GE Healthcare(United States), Editas Medicine (United States), Agilent Technologies (United States), QIAGEN NV (Germany) and Allele Biotech (United States) are some of the key players that are part of study coverage. Additionally, the Players which are also part of the research coverage are AstraZeneca (United Kingdom), Bio Rad (United States), Recombinetics (Switzerland) and Lonza(Switzerland).

Segmentation Overview
AMA Research has segmented the market of Global Gene Editing Technology market by , Application (Agriculture, Medical and Other) and Region.



On the basis of geography, the market of Gene Editing Technology has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). If we see Market by Technology, the sub-segment i.e. CRISPR will boost the Gene Editing Technology market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by product & service, the sub-segment i.e. Reagents & Consumables will boost the Gene Editing Technology market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by End User, the sub-segment i.e. Pharmaceutical Companies will boost the Gene Editing Technology market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.

Influencing Trend:
The increased research and development activity

Market Growth Drivers:
Growing government funding and growth in the number of genomics projects and The rise in the application areas of genomics

Challenges:
Lack of skilled professionals

Restraints:
High equipment costs

Opportunities:
The wide use of genome editing in personalized medicine

Market Leaders and their expansionary development strategies
In June 2019 Vertex United States Expands into New Disease Areas and Enhances Gene Editing Capabilities Through Expanded Collaboration with CRISPR Therapeutics and Acquisition of Exonics Therapeutics.
In September 2020 Graphite Bio United States-based organization has launched with USD45 million in Series A financing and an objective to utilize gene editing to correct defective genes through a high-productivity site-explicit mix of new hereditary arrangements. The organization was upheld by Versant Ventures, which upheld the dispatch of CRISPR Therapeutics.


Key Target Audience
New Entrants/Investors, Analysts and Strategic Business Planners, Gene Editing Technology Manufacturer, Government Regulatory and Research Organizations and End-Use Industry

About Approach
To evaluate and validate the market size various sources including primary and secondary analysis is utilized. AMA Research follows regulatory standards such as NAICS/SIC/ICB/TRCB, to have a better understanding of the market. The market study is conducted on basis of more than 200 companies dealing in the market regional as well as global areas with the purpose to understand the companies positioning regarding the market value, volume, and their market share for regional as well as global.

Further to bring relevance specific to any niche market we set and apply a number of criteria like Geographic Footprints, Regional Segments of Revenue, Operational Centres, etc. The next step is to finalize a team (In-House + Data Agencies) who then starts collecting C & D level executives and profiles, Industry experts, Opinion leaders, etc., and work towards appointment generation.

The primary research is performed by taking the interviews of executives of various companies dealing in the market as well as using the survey reports, research institute, and latest research reports. Meanwhile, the analyst team keeps preparing a set of questionnaires, and after getting the appointee list; the target audience is then tapped and segregated with various mediums and channels that are feasible for making connections that including email communication, telephonic, skype, LinkedIn Group & InMail, Community Forums, Community Forums, open Survey, SurveyMonkey, etc.

Report Objectives / Segmentation Covered

By Application
  • Agriculture
  • Medical
  • Other
By Technology
  • CRISPR
  • TALEN
  • ZFN
  • Antisense
  • Other

By product & service
  • Reagents & Consumables
  • Software & Systems
  • Services

By End User
  • Pharmaceutical Companies
  • Biotechnology Companies
  • Academic & Government Research Institutes

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Growing government funding and growth in the number of genomics projects
      • 3.2.2. The rise in the application areas of genomics
    • 3.3. Market Challenges
      • 3.3.1. Lack of skilled professionals
    • 3.4. Market Trends
      • 3.4.1. The increased research and development activity
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Gene Editing Technology, by Application, Technology, product & service, End User and Region (value and price ) (2018-2023)
    • 5.1. Introduction
    • 5.2. Global Gene Editing Technology (Value)
      • 5.2.1. Global Gene Editing Technology by: Application (Value)
        • 5.2.1.1. Agriculture
        • 5.2.1.2. Medical
        • 5.2.1.3. Other
      • 5.2.2. Global Gene Editing Technology by: Technology (Value)
        • 5.2.2.1. CRISPR
        • 5.2.2.2. TALEN
        • 5.2.2.3. ZFN
        • 5.2.2.4. Antisense
        • 5.2.2.5. Other
      • 5.2.3. Global Gene Editing Technology by: End User (Value)
        • 5.2.3.1. Pharmaceutical Companies
        • 5.2.3.2. Biotechnology Companies
        • 5.2.3.3. Academic & Government Research Institutes
      • 5.2.4. Global Gene Editing Technology Region
        • 5.2.4.1. South America
          • 5.2.4.1.1. Brazil
          • 5.2.4.1.2. Argentina
          • 5.2.4.1.3. Rest of South America
        • 5.2.4.2. Asia Pacific
          • 5.2.4.2.1. China
          • 5.2.4.2.2. Japan
          • 5.2.4.2.3. India
          • 5.2.4.2.4. South Korea
          • 5.2.4.2.5. Taiwan
          • 5.2.4.2.6. Australia
          • 5.2.4.2.7. Rest of Asia-Pacific
        • 5.2.4.3. Europe
          • 5.2.4.3.1. Germany
          • 5.2.4.3.2. France
          • 5.2.4.3.3. Italy
          • 5.2.4.3.4. United Kingdom
          • 5.2.4.3.5. Netherlands
          • 5.2.4.3.6. Rest of Europe
        • 5.2.4.4. MEA
          • 5.2.4.4.1. Middle East
          • 5.2.4.4.2. Africa
        • 5.2.4.5. North America
          • 5.2.4.5.1. United States
          • 5.2.4.5.2. Canada
          • 5.2.4.5.3. Mexico
    • 5.3. Global Gene Editing Technology (Price)
  • 6. Gene Editing Technology: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2023)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Thermo Fisher Scientific(United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. SIGMA ALDRICH(United States)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Cellectics(France)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. CRISPR Therapeutics (Switzerland)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. GE Healthcare(United States)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Editas Medicine (United States)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Agilent Technologies (United States)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. QIAGEN NV (Germany)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Allele Biotech (United States)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
  • 7. Global Gene Editing Technology Sale, by Application, Technology, product & service, End User and Region (value and price ) (2025-2030)
    • 7.1. Introduction
    • 7.2. Global Gene Editing Technology (Value)
      • 7.2.1. Global Gene Editing Technology by: Application (Value)
        • 7.2.1.1. Agriculture
        • 7.2.1.2. Medical
        • 7.2.1.3. Other
      • 7.2.2. Global Gene Editing Technology by: Technology (Value)
        • 7.2.2.1. CRISPR
        • 7.2.2.2. TALEN
        • 7.2.2.3. ZFN
        • 7.2.2.4. Antisense
        • 7.2.2.5. Other
      • 7.2.3. Global Gene Editing Technology by: End User (Value)
        • 7.2.3.1. Pharmaceutical Companies
        • 7.2.3.2. Biotechnology Companies
        • 7.2.3.3. Academic & Government Research Institutes
      • 7.2.4. Global Gene Editing Technology Region
        • 7.2.4.1. South America
          • 7.2.4.1.1. Brazil
          • 7.2.4.1.2. Argentina
          • 7.2.4.1.3. Rest of South America
        • 7.2.4.2. Asia Pacific
          • 7.2.4.2.1. China
          • 7.2.4.2.2. Japan
          • 7.2.4.2.3. India
          • 7.2.4.2.4. South Korea
          • 7.2.4.2.5. Taiwan
          • 7.2.4.2.6. Australia
          • 7.2.4.2.7. Rest of Asia-Pacific
        • 7.2.4.3. Europe
          • 7.2.4.3.1. Germany
          • 7.2.4.3.2. France
          • 7.2.4.3.3. Italy
          • 7.2.4.3.4. United Kingdom
          • 7.2.4.3.5. Netherlands
          • 7.2.4.3.6. Rest of Europe
        • 7.2.4.4. MEA
          • 7.2.4.4.1. Middle East
          • 7.2.4.4.2. Africa
        • 7.2.4.5. North America
          • 7.2.4.5.1. United States
          • 7.2.4.5.2. Canada
          • 7.2.4.5.3. Mexico
    • 7.3. Global Gene Editing Technology (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Gene Editing Technology: by Application(USD Million)
  • Table 2. Gene Editing Technology Agriculture , by Region USD Million (2018-2023)
  • Table 3. Gene Editing Technology Medical , by Region USD Million (2018-2023)
  • Table 4. Gene Editing Technology Other , by Region USD Million (2018-2023)
  • Table 5. Gene Editing Technology: by Technology(USD Million)
  • Table 6. Gene Editing Technology CRISPR , by Region USD Million (2018-2023)
  • Table 7. Gene Editing Technology TALEN , by Region USD Million (2018-2023)
  • Table 8. Gene Editing Technology ZFN , by Region USD Million (2018-2023)
  • Table 9. Gene Editing Technology Antisense , by Region USD Million (2018-2023)
  • Table 10. Gene Editing Technology Other , by Region USD Million (2018-2023)
  • Table 11. Gene Editing Technology: by End User(USD Million)
  • Table 12. Gene Editing Technology Pharmaceutical Companies , by Region USD Million (2018-2023)
  • Table 13. Gene Editing Technology Biotechnology Companies , by Region USD Million (2018-2023)
  • Table 14. Gene Editing Technology Academic & Government Research Institutes , by Region USD Million (2018-2023)
  • Table 15. South America Gene Editing Technology, by Country USD Million (2018-2023)
  • Table 16. South America Gene Editing Technology, by Application USD Million (2018-2023)
  • Table 17. South America Gene Editing Technology, by Technology USD Million (2018-2023)
  • Table 18. South America Gene Editing Technology, by product & service USD Million (2018-2023)
  • Table 19. South America Gene Editing Technology, by End User USD Million (2018-2023)
  • Table 20. Brazil Gene Editing Technology, by Application USD Million (2018-2023)
  • Table 21. Brazil Gene Editing Technology, by Technology USD Million (2018-2023)
  • Table 22. Brazil Gene Editing Technology, by product & service USD Million (2018-2023)
  • Table 23. Brazil Gene Editing Technology, by End User USD Million (2018-2023)
  • Table 24. Argentina Gene Editing Technology, by Application USD Million (2018-2023)
  • Table 25. Argentina Gene Editing Technology, by Technology USD Million (2018-2023)
  • Table 26. Argentina Gene Editing Technology, by product & service USD Million (2018-2023)
  • Table 27. Argentina Gene Editing Technology, by End User USD Million (2018-2023)
  • Table 28. Rest of South America Gene Editing Technology, by Application USD Million (2018-2023)
  • Table 29. Rest of South America Gene Editing Technology, by Technology USD Million (2018-2023)
  • Table 30. Rest of South America Gene Editing Technology, by product & service USD Million (2018-2023)
  • Table 31. Rest of South America Gene Editing Technology, by End User USD Million (2018-2023)
  • Table 32. Asia Pacific Gene Editing Technology, by Country USD Million (2018-2023)
  • Table 33. Asia Pacific Gene Editing Technology, by Application USD Million (2018-2023)
  • Table 34. Asia Pacific Gene Editing Technology, by Technology USD Million (2018-2023)
  • Table 35. Asia Pacific Gene Editing Technology, by product & service USD Million (2018-2023)
  • Table 36. Asia Pacific Gene Editing Technology, by End User USD Million (2018-2023)
  • Table 37. China Gene Editing Technology, by Application USD Million (2018-2023)
  • Table 38. China Gene Editing Technology, by Technology USD Million (2018-2023)
  • Table 39. China Gene Editing Technology, by product & service USD Million (2018-2023)
  • Table 40. China Gene Editing Technology, by End User USD Million (2018-2023)
  • Table 41. Japan Gene Editing Technology, by Application USD Million (2018-2023)
  • Table 42. Japan Gene Editing Technology, by Technology USD Million (2018-2023)
  • Table 43. Japan Gene Editing Technology, by product & service USD Million (2018-2023)
  • Table 44. Japan Gene Editing Technology, by End User USD Million (2018-2023)
  • Table 45. India Gene Editing Technology, by Application USD Million (2018-2023)
  • Table 46. India Gene Editing Technology, by Technology USD Million (2018-2023)
  • Table 47. India Gene Editing Technology, by product & service USD Million (2018-2023)
  • Table 48. India Gene Editing Technology, by End User USD Million (2018-2023)
  • Table 49. South Korea Gene Editing Technology, by Application USD Million (2018-2023)
  • Table 50. South Korea Gene Editing Technology, by Technology USD Million (2018-2023)
  • Table 51. South Korea Gene Editing Technology, by product & service USD Million (2018-2023)
  • Table 52. South Korea Gene Editing Technology, by End User USD Million (2018-2023)
  • Table 53. Taiwan Gene Editing Technology, by Application USD Million (2018-2023)
  • Table 54. Taiwan Gene Editing Technology, by Technology USD Million (2018-2023)
  • Table 55. Taiwan Gene Editing Technology, by product & service USD Million (2018-2023)
  • Table 56. Taiwan Gene Editing Technology, by End User USD Million (2018-2023)
  • Table 57. Australia Gene Editing Technology, by Application USD Million (2018-2023)
  • Table 58. Australia Gene Editing Technology, by Technology USD Million (2018-2023)
  • Table 59. Australia Gene Editing Technology, by product & service USD Million (2018-2023)
  • Table 60. Australia Gene Editing Technology, by End User USD Million (2018-2023)
  • Table 61. Rest of Asia-Pacific Gene Editing Technology, by Application USD Million (2018-2023)
  • Table 62. Rest of Asia-Pacific Gene Editing Technology, by Technology USD Million (2018-2023)
  • Table 63. Rest of Asia-Pacific Gene Editing Technology, by product & service USD Million (2018-2023)
  • Table 64. Rest of Asia-Pacific Gene Editing Technology, by End User USD Million (2018-2023)
  • Table 65. Europe Gene Editing Technology, by Country USD Million (2018-2023)
  • Table 66. Europe Gene Editing Technology, by Application USD Million (2018-2023)
  • Table 67. Europe Gene Editing Technology, by Technology USD Million (2018-2023)
  • Table 68. Europe Gene Editing Technology, by product & service USD Million (2018-2023)
  • Table 69. Europe Gene Editing Technology, by End User USD Million (2018-2023)
  • Table 70. Germany Gene Editing Technology, by Application USD Million (2018-2023)
  • Table 71. Germany Gene Editing Technology, by Technology USD Million (2018-2023)
  • Table 72. Germany Gene Editing Technology, by product & service USD Million (2018-2023)
  • Table 73. Germany Gene Editing Technology, by End User USD Million (2018-2023)
  • Table 74. France Gene Editing Technology, by Application USD Million (2018-2023)
  • Table 75. France Gene Editing Technology, by Technology USD Million (2018-2023)
  • Table 76. France Gene Editing Technology, by product & service USD Million (2018-2023)
  • Table 77. France Gene Editing Technology, by End User USD Million (2018-2023)
  • Table 78. Italy Gene Editing Technology, by Application USD Million (2018-2023)
  • Table 79. Italy Gene Editing Technology, by Technology USD Million (2018-2023)
  • Table 80. Italy Gene Editing Technology, by product & service USD Million (2018-2023)
  • Table 81. Italy Gene Editing Technology, by End User USD Million (2018-2023)
  • Table 82. United Kingdom Gene Editing Technology, by Application USD Million (2018-2023)
  • Table 83. United Kingdom Gene Editing Technology, by Technology USD Million (2018-2023)
  • Table 84. United Kingdom Gene Editing Technology, by product & service USD Million (2018-2023)
  • Table 85. United Kingdom Gene Editing Technology, by End User USD Million (2018-2023)
  • Table 86. Netherlands Gene Editing Technology, by Application USD Million (2018-2023)
  • Table 87. Netherlands Gene Editing Technology, by Technology USD Million (2018-2023)
  • Table 88. Netherlands Gene Editing Technology, by product & service USD Million (2018-2023)
  • Table 89. Netherlands Gene Editing Technology, by End User USD Million (2018-2023)
  • Table 90. Rest of Europe Gene Editing Technology, by Application USD Million (2018-2023)
  • Table 91. Rest of Europe Gene Editing Technology, by Technology USD Million (2018-2023)
  • Table 92. Rest of Europe Gene Editing Technology, by product & service USD Million (2018-2023)
  • Table 93. Rest of Europe Gene Editing Technology, by End User USD Million (2018-2023)
  • Table 94. MEA Gene Editing Technology, by Country USD Million (2018-2023)
  • Table 95. MEA Gene Editing Technology, by Application USD Million (2018-2023)
  • Table 96. MEA Gene Editing Technology, by Technology USD Million (2018-2023)
  • Table 97. MEA Gene Editing Technology, by product & service USD Million (2018-2023)
  • Table 98. MEA Gene Editing Technology, by End User USD Million (2018-2023)
  • Table 99. Middle East Gene Editing Technology, by Application USD Million (2018-2023)
  • Table 100. Middle East Gene Editing Technology, by Technology USD Million (2018-2023)
  • Table 101. Middle East Gene Editing Technology, by product & service USD Million (2018-2023)
  • Table 102. Middle East Gene Editing Technology, by End User USD Million (2018-2023)
  • Table 103. Africa Gene Editing Technology, by Application USD Million (2018-2023)
  • Table 104. Africa Gene Editing Technology, by Technology USD Million (2018-2023)
  • Table 105. Africa Gene Editing Technology, by product & service USD Million (2018-2023)
  • Table 106. Africa Gene Editing Technology, by End User USD Million (2018-2023)
  • Table 107. North America Gene Editing Technology, by Country USD Million (2018-2023)
  • Table 108. North America Gene Editing Technology, by Application USD Million (2018-2023)
  • Table 109. North America Gene Editing Technology, by Technology USD Million (2018-2023)
  • Table 110. North America Gene Editing Technology, by product & service USD Million (2018-2023)
  • Table 111. North America Gene Editing Technology, by End User USD Million (2018-2023)
  • Table 112. United States Gene Editing Technology, by Application USD Million (2018-2023)
  • Table 113. United States Gene Editing Technology, by Technology USD Million (2018-2023)
  • Table 114. United States Gene Editing Technology, by product & service USD Million (2018-2023)
  • Table 115. United States Gene Editing Technology, by End User USD Million (2018-2023)
  • Table 116. Canada Gene Editing Technology, by Application USD Million (2018-2023)
  • Table 117. Canada Gene Editing Technology, by Technology USD Million (2018-2023)
  • Table 118. Canada Gene Editing Technology, by product & service USD Million (2018-2023)
  • Table 119. Canada Gene Editing Technology, by End User USD Million (2018-2023)
  • Table 120. Mexico Gene Editing Technology, by Application USD Million (2018-2023)
  • Table 121. Mexico Gene Editing Technology, by Technology USD Million (2018-2023)
  • Table 122. Mexico Gene Editing Technology, by product & service USD Million (2018-2023)
  • Table 123. Mexico Gene Editing Technology, by End User USD Million (2018-2023)
  • Table 124. Company Basic Information, Sales Area and Its Competitors
  • Table 125. Company Basic Information, Sales Area and Its Competitors
  • Table 126. Company Basic Information, Sales Area and Its Competitors
  • Table 127. Company Basic Information, Sales Area and Its Competitors
  • Table 128. Company Basic Information, Sales Area and Its Competitors
  • Table 129. Company Basic Information, Sales Area and Its Competitors
  • Table 130. Company Basic Information, Sales Area and Its Competitors
  • Table 131. Company Basic Information, Sales Area and Its Competitors
  • Table 132. Company Basic Information, Sales Area and Its Competitors
  • Table 133. Gene Editing Technology: by Application(USD Million)
  • Table 134. Gene Editing Technology Agriculture , by Region USD Million (2025-2030)
  • Table 135. Gene Editing Technology Medical , by Region USD Million (2025-2030)
  • Table 136. Gene Editing Technology Other , by Region USD Million (2025-2030)
  • Table 137. Gene Editing Technology: by Technology(USD Million)
  • Table 138. Gene Editing Technology CRISPR , by Region USD Million (2025-2030)
  • Table 139. Gene Editing Technology TALEN , by Region USD Million (2025-2030)
  • Table 140. Gene Editing Technology ZFN , by Region USD Million (2025-2030)
  • Table 141. Gene Editing Technology Antisense , by Region USD Million (2025-2030)
  • Table 142. Gene Editing Technology Other , by Region USD Million (2025-2030)
  • Table 143. Gene Editing Technology: by End User(USD Million)
  • Table 144. Gene Editing Technology Pharmaceutical Companies , by Region USD Million (2025-2030)
  • Table 145. Gene Editing Technology Biotechnology Companies , by Region USD Million (2025-2030)
  • Table 146. Gene Editing Technology Academic & Government Research Institutes , by Region USD Million (2025-2030)
  • Table 147. South America Gene Editing Technology, by Country USD Million (2025-2030)
  • Table 148. South America Gene Editing Technology, by Application USD Million (2025-2030)
  • Table 149. South America Gene Editing Technology, by Technology USD Million (2025-2030)
  • Table 150. South America Gene Editing Technology, by product & service USD Million (2025-2030)
  • Table 151. South America Gene Editing Technology, by End User USD Million (2025-2030)
  • Table 152. Brazil Gene Editing Technology, by Application USD Million (2025-2030)
  • Table 153. Brazil Gene Editing Technology, by Technology USD Million (2025-2030)
  • Table 154. Brazil Gene Editing Technology, by product & service USD Million (2025-2030)
  • Table 155. Brazil Gene Editing Technology, by End User USD Million (2025-2030)
  • Table 156. Argentina Gene Editing Technology, by Application USD Million (2025-2030)
  • Table 157. Argentina Gene Editing Technology, by Technology USD Million (2025-2030)
  • Table 158. Argentina Gene Editing Technology, by product & service USD Million (2025-2030)
  • Table 159. Argentina Gene Editing Technology, by End User USD Million (2025-2030)
  • Table 160. Rest of South America Gene Editing Technology, by Application USD Million (2025-2030)
  • Table 161. Rest of South America Gene Editing Technology, by Technology USD Million (2025-2030)
  • Table 162. Rest of South America Gene Editing Technology, by product & service USD Million (2025-2030)
  • Table 163. Rest of South America Gene Editing Technology, by End User USD Million (2025-2030)
  • Table 164. Asia Pacific Gene Editing Technology, by Country USD Million (2025-2030)
  • Table 165. Asia Pacific Gene Editing Technology, by Application USD Million (2025-2030)
  • Table 166. Asia Pacific Gene Editing Technology, by Technology USD Million (2025-2030)
  • Table 167. Asia Pacific Gene Editing Technology, by product & service USD Million (2025-2030)
  • Table 168. Asia Pacific Gene Editing Technology, by End User USD Million (2025-2030)
  • Table 169. China Gene Editing Technology, by Application USD Million (2025-2030)
  • Table 170. China Gene Editing Technology, by Technology USD Million (2025-2030)
  • Table 171. China Gene Editing Technology, by product & service USD Million (2025-2030)
  • Table 172. China Gene Editing Technology, by End User USD Million (2025-2030)
  • Table 173. Japan Gene Editing Technology, by Application USD Million (2025-2030)
  • Table 174. Japan Gene Editing Technology, by Technology USD Million (2025-2030)
  • Table 175. Japan Gene Editing Technology, by product & service USD Million (2025-2030)
  • Table 176. Japan Gene Editing Technology, by End User USD Million (2025-2030)
  • Table 177. India Gene Editing Technology, by Application USD Million (2025-2030)
  • Table 178. India Gene Editing Technology, by Technology USD Million (2025-2030)
  • Table 179. India Gene Editing Technology, by product & service USD Million (2025-2030)
  • Table 180. India Gene Editing Technology, by End User USD Million (2025-2030)
  • Table 181. South Korea Gene Editing Technology, by Application USD Million (2025-2030)
  • Table 182. South Korea Gene Editing Technology, by Technology USD Million (2025-2030)
  • Table 183. South Korea Gene Editing Technology, by product & service USD Million (2025-2030)
  • Table 184. South Korea Gene Editing Technology, by End User USD Million (2025-2030)
  • Table 185. Taiwan Gene Editing Technology, by Application USD Million (2025-2030)
  • Table 186. Taiwan Gene Editing Technology, by Technology USD Million (2025-2030)
  • Table 187. Taiwan Gene Editing Technology, by product & service USD Million (2025-2030)
  • Table 188. Taiwan Gene Editing Technology, by End User USD Million (2025-2030)
  • Table 189. Australia Gene Editing Technology, by Application USD Million (2025-2030)
  • Table 190. Australia Gene Editing Technology, by Technology USD Million (2025-2030)
  • Table 191. Australia Gene Editing Technology, by product & service USD Million (2025-2030)
  • Table 192. Australia Gene Editing Technology, by End User USD Million (2025-2030)
  • Table 193. Rest of Asia-Pacific Gene Editing Technology, by Application USD Million (2025-2030)
  • Table 194. Rest of Asia-Pacific Gene Editing Technology, by Technology USD Million (2025-2030)
  • Table 195. Rest of Asia-Pacific Gene Editing Technology, by product & service USD Million (2025-2030)
  • Table 196. Rest of Asia-Pacific Gene Editing Technology, by End User USD Million (2025-2030)
  • Table 197. Europe Gene Editing Technology, by Country USD Million (2025-2030)
  • Table 198. Europe Gene Editing Technology, by Application USD Million (2025-2030)
  • Table 199. Europe Gene Editing Technology, by Technology USD Million (2025-2030)
  • Table 200. Europe Gene Editing Technology, by product & service USD Million (2025-2030)
  • Table 201. Europe Gene Editing Technology, by End User USD Million (2025-2030)
  • Table 202. Germany Gene Editing Technology, by Application USD Million (2025-2030)
  • Table 203. Germany Gene Editing Technology, by Technology USD Million (2025-2030)
  • Table 204. Germany Gene Editing Technology, by product & service USD Million (2025-2030)
  • Table 205. Germany Gene Editing Technology, by End User USD Million (2025-2030)
  • Table 206. France Gene Editing Technology, by Application USD Million (2025-2030)
  • Table 207. France Gene Editing Technology, by Technology USD Million (2025-2030)
  • Table 208. France Gene Editing Technology, by product & service USD Million (2025-2030)
  • Table 209. France Gene Editing Technology, by End User USD Million (2025-2030)
  • Table 210. Italy Gene Editing Technology, by Application USD Million (2025-2030)
  • Table 211. Italy Gene Editing Technology, by Technology USD Million (2025-2030)
  • Table 212. Italy Gene Editing Technology, by product & service USD Million (2025-2030)
  • Table 213. Italy Gene Editing Technology, by End User USD Million (2025-2030)
  • Table 214. United Kingdom Gene Editing Technology, by Application USD Million (2025-2030)
  • Table 215. United Kingdom Gene Editing Technology, by Technology USD Million (2025-2030)
  • Table 216. United Kingdom Gene Editing Technology, by product & service USD Million (2025-2030)
  • Table 217. United Kingdom Gene Editing Technology, by End User USD Million (2025-2030)
  • Table 218. Netherlands Gene Editing Technology, by Application USD Million (2025-2030)
  • Table 219. Netherlands Gene Editing Technology, by Technology USD Million (2025-2030)
  • Table 220. Netherlands Gene Editing Technology, by product & service USD Million (2025-2030)
  • Table 221. Netherlands Gene Editing Technology, by End User USD Million (2025-2030)
  • Table 222. Rest of Europe Gene Editing Technology, by Application USD Million (2025-2030)
  • Table 223. Rest of Europe Gene Editing Technology, by Technology USD Million (2025-2030)
  • Table 224. Rest of Europe Gene Editing Technology, by product & service USD Million (2025-2030)
  • Table 225. Rest of Europe Gene Editing Technology, by End User USD Million (2025-2030)
  • Table 226. MEA Gene Editing Technology, by Country USD Million (2025-2030)
  • Table 227. MEA Gene Editing Technology, by Application USD Million (2025-2030)
  • Table 228. MEA Gene Editing Technology, by Technology USD Million (2025-2030)
  • Table 229. MEA Gene Editing Technology, by product & service USD Million (2025-2030)
  • Table 230. MEA Gene Editing Technology, by End User USD Million (2025-2030)
  • Table 231. Middle East Gene Editing Technology, by Application USD Million (2025-2030)
  • Table 232. Middle East Gene Editing Technology, by Technology USD Million (2025-2030)
  • Table 233. Middle East Gene Editing Technology, by product & service USD Million (2025-2030)
  • Table 234. Middle East Gene Editing Technology, by End User USD Million (2025-2030)
  • Table 235. Africa Gene Editing Technology, by Application USD Million (2025-2030)
  • Table 236. Africa Gene Editing Technology, by Technology USD Million (2025-2030)
  • Table 237. Africa Gene Editing Technology, by product & service USD Million (2025-2030)
  • Table 238. Africa Gene Editing Technology, by End User USD Million (2025-2030)
  • Table 239. North America Gene Editing Technology, by Country USD Million (2025-2030)
  • Table 240. North America Gene Editing Technology, by Application USD Million (2025-2030)
  • Table 241. North America Gene Editing Technology, by Technology USD Million (2025-2030)
  • Table 242. North America Gene Editing Technology, by product & service USD Million (2025-2030)
  • Table 243. North America Gene Editing Technology, by End User USD Million (2025-2030)
  • Table 244. United States Gene Editing Technology, by Application USD Million (2025-2030)
  • Table 245. United States Gene Editing Technology, by Technology USD Million (2025-2030)
  • Table 246. United States Gene Editing Technology, by product & service USD Million (2025-2030)
  • Table 247. United States Gene Editing Technology, by End User USD Million (2025-2030)
  • Table 248. Canada Gene Editing Technology, by Application USD Million (2025-2030)
  • Table 249. Canada Gene Editing Technology, by Technology USD Million (2025-2030)
  • Table 250. Canada Gene Editing Technology, by product & service USD Million (2025-2030)
  • Table 251. Canada Gene Editing Technology, by End User USD Million (2025-2030)
  • Table 252. Mexico Gene Editing Technology, by Application USD Million (2025-2030)
  • Table 253. Mexico Gene Editing Technology, by Technology USD Million (2025-2030)
  • Table 254. Mexico Gene Editing Technology, by product & service USD Million (2025-2030)
  • Table 255. Mexico Gene Editing Technology, by End User USD Million (2025-2030)
  • Table 256. Research Programs/Design for This Report
  • Table 257. Key Data Information from Secondary Sources
  • Table 258. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Gene Editing Technology: by Application USD Million (2018-2023)
  • Figure 5. Global Gene Editing Technology: by Technology USD Million (2018-2023)
  • Figure 6. Global Gene Editing Technology: by End User USD Million (2018-2023)
  • Figure 7. South America Gene Editing Technology Share (%), by Country
  • Figure 8. Asia Pacific Gene Editing Technology Share (%), by Country
  • Figure 9. Europe Gene Editing Technology Share (%), by Country
  • Figure 10. MEA Gene Editing Technology Share (%), by Country
  • Figure 11. North America Gene Editing Technology Share (%), by Country
  • Figure 12. Global Gene Editing Technology share by Players 2023 (%)
  • Figure 13. Global Gene Editing Technology share by Players (Top 3) 2023(%)
  • Figure 14. Global Gene Editing Technology share by Players (Top 5) 2023(%)
  • Figure 15. BCG Matrix for key Companies
  • Figure 16. Thermo Fisher Scientific(United States) Revenue, Net Income and Gross profit
  • Figure 17. Thermo Fisher Scientific(United States) Revenue: by Geography 2023
  • Figure 18. SIGMA ALDRICH(United States) Revenue, Net Income and Gross profit
  • Figure 19. SIGMA ALDRICH(United States) Revenue: by Geography 2023
  • Figure 20. Cellectics(France) Revenue, Net Income and Gross profit
  • Figure 21. Cellectics(France) Revenue: by Geography 2023
  • Figure 22. CRISPR Therapeutics (Switzerland) Revenue, Net Income and Gross profit
  • Figure 23. CRISPR Therapeutics (Switzerland) Revenue: by Geography 2023
  • Figure 24. GE Healthcare(United States) Revenue, Net Income and Gross profit
  • Figure 25. GE Healthcare(United States) Revenue: by Geography 2023
  • Figure 26. Editas Medicine (United States) Revenue, Net Income and Gross profit
  • Figure 27. Editas Medicine (United States) Revenue: by Geography 2023
  • Figure 28. Agilent Technologies (United States) Revenue, Net Income and Gross profit
  • Figure 29. Agilent Technologies (United States) Revenue: by Geography 2023
  • Figure 30. QIAGEN NV (Germany) Revenue, Net Income and Gross profit
  • Figure 31. QIAGEN NV (Germany) Revenue: by Geography 2023
  • Figure 32. Allele Biotech (United States) Revenue, Net Income and Gross profit
  • Figure 33. Allele Biotech (United States) Revenue: by Geography 2023
  • Figure 34. Global Gene Editing Technology: by Application USD Million (2025-2030)
  • Figure 35. Global Gene Editing Technology: by Technology USD Million (2025-2030)
  • Figure 36. Global Gene Editing Technology: by End User USD Million (2025-2030)
  • Figure 37. South America Gene Editing Technology Share (%), by Country
  • Figure 38. Asia Pacific Gene Editing Technology Share (%), by Country
  • Figure 39. Europe Gene Editing Technology Share (%), by Country
  • Figure 40. MEA Gene Editing Technology Share (%), by Country
  • Figure 41. North America Gene Editing Technology Share (%), by Country
List of companies from research coverage that are profiled in the study
  • Thermo Fisher Scientific(United States)
  • SIGMA ALDRICH(United States)
  • Cellectics(France)
  • CRISPR Therapeutics (Switzerland)
  • GE Healthcare(United States)
  • Editas Medicine (United States)
  • Agilent Technologies (United States)
  • QIAGEN NV (Germany)
  • Allele Biotech (United States)
Additional players considered in the study are as follows:
AstraZeneca (United Kingdom) , Bio Rad (United States) , Recombinetics (Switzerland) , Lonza(Switzerland)
Select User Access Type

Key Highlights of Report


Apr 2024 238 Pages 92 Tables Base Year: 2023 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Gene Editing Technology Quantitative research analysis
Global Gene Editing Technology Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

The standard version of the report profiles players such as Thermo Fisher Scientific(United States), SIGMA ALDRICH(United States), Cellectics(France), CRISPR Therapeutics (Switzerland), GE Healthcare(United States), Editas Medicine (United States), Agilent Technologies (United States), QIAGEN NV (Germany) and Allele Biotech (United States) etc.
The Study can be customized subject to feasibility and data availability. Please connect with our sales representative for further information.
"The increased research and development activity" is seen as one of major influencing trends for Gene Editing Technology Market during projected period 2023-2030.
The Gene Editing Technology market study includes a random mix of players, including both market leaders and some top growing emerging players. Connect with our sales executive to get a complete company list in our research coverage.

Know More About Global Gene Editing Technology Report?

Have a Query? Click Here

Other Related Reports

COVID-19 CRISPR Technology Comprehensive Study by Type (Enzymes, Kits, GRNA, Libraries, Design Tools), End-users (Pharma & Biopharma Companies, Academics, CROs), Distribution Channel (Hospital Pharma...
$ 3450
Pharma Clinical Trial Digitization Comprehensive Study by Application (Pharmaceutical Companies, Biotechnology Companies, Academic and Government Research Institutes, Others), Trial Types (Digital Co...
$ 3750
Brain Computer Interface Technology Comprehensive Study by Type (Invasive BCI, Non Invasive BCI), Components (Signal Acquisition, Feature Extraction, Feature Translation, Device Output), Industry Ver...
$ 3650
Total Lab Automation Comprehensive Study by Application (Drug Discovery, Clinical Diagnostics, Proteomics Solutions, Genomics), Software Type (Laboratory Information Management System (LIMS), Laborat...
$ 3750
Digital Transformation in Healthcare Comprehensive Study by Organization Size (Large Enterprises, SMEs), Technology (Artificial Intelligence (AI), Cloud Computing, Big data and Analytics, Internet of...
$ 3750
Covid-19 Impact on Telemedicine Technologies and Services Comprehensive Study by Application (Dermatology, Gynecology, Neurology, Cardiology, Orthopedics, Others), Solutions (Hardware (Telemedicine K...
$ 3750